Revenue: The sum of all revenue fields included for a company's operating activities.
Sinovac Biotech, Ltd. (SVA) had Revenue of $448.27M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$448.27M |
$-105.90M |
|
$181.52M |
|
$266.75M |
|
$1.05B |
|
$-603.02M |
|
$449.99M |
|
$-153.03M |
|
$-153.03M |
|
$-258.36M |
|
$-258.36M |
|
$-258.36M |
|
$-258.36M |
|
$-603.02M |
|
$-460.50M |
|
99.61M |
|
99.61M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$11.83B |
|
$979.62M |
|
$1.83B |
|
$13.66B |
|
$1.15B |
|
$177.82M |
|
$487.30M |
|
$1.64B |
|
$12.02B |
|
$12.01B |
|
$12.02B |
|
99.64M |
|
| Cash Flow Statement Financials | |
$104.00M |
|
$-2.92B |
|
$-76.06M |
|
$4.29B |
|
$1.28B |
|
$-3.01B |
|
-- |
|
$-328.08M |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.31 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
59.51% |
|
-134.52% |
|
-134.52% |
|
-102.73% |
|
-34.14% |
|
-23.62% |
|
$-40.51M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.30 |
|
0.99 |
|
367.00 |
|
-2.15% |
|
-2.15% |
|
-1.89% |
|
-2.12% |
|
$120.66 |
|
$-0.41 |
|
$1.04 |
|